Altrova Health Announces First U.S. Sale of 2,000 O-Spray Units
Toronto, Ontario--(Newsfile Corp. - October 19, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today announced the sale of 2,000 units of its O-Spray™ product pursuant to a sales agreement dated October 17, 2026, to a distributor of peptide products with a large network of healthcare practitioners and retail channels (the "Purchaser"). The sale marks the Company's entry into the United States market.O-Spray is a needle-free sublingual oral...
Free plan · Plus CA$29 or Pro CA$99/month


